EFFECT OF POSTOPERATIVE I-131 TREATMENT ON THYROGLOBULIN MEASUREMENTS IN THE FOLLOW-UP OF PATIENTS WITH THYROID-CANCER

被引:18
作者
BASKIN, HJ
机构
[1] Florida Thyroid and Endocrine Clinic, Orlando, FL 32804
关键词
D O I
10.1089/thy.1994.4.239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Correlation of serum thyroglobulin (Tg) levels with recurrent cancer was performed in 200 patients who had undergone a subtotal thyroidectomy for well-differentiated thyroid carcinoma. Patients were divided into three groups: (1) those not treated postoperatively with radioactive iodine, (2) those treated with low dose (30 mCi) radioactive iodine, and (3) those treated with high dose (50-250 mCi) radioactive iodine. Tg levels proved to be reliable in detecting recurrent thyroid cancer regardless of the dose of radioactive iodine given postoperatively. These results reinforce the recommendation of using the Tg assay as the primary method of following these patients postoperatively, even when there was less than a total thyroidectomy and ablation with radioactive iodine.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 25 条
  • [1] THE COMPARATIVE VALUE OF SERUM THYROGLOBULIN MEASUREMENTS AND I-131 TOTAL-BODY SCANS IN THE FOLLOW-UP-STUDY OF PATIENTS WITH TREATED DIFFERENTIATED THYROID-CANCER
    ASHCRAFT, MW
    VANHERLE, AJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (05) : 806 - 814
  • [2] SERIAL SERUM THYROGLOBULIN MEASUREMENTS IN THE MANAGEMENT OF DIFFERENTIATED THYROID-CARCINOMA
    BLACK, EG
    SHEPPARD, MC
    HOFFENBERG, R
    [J]. CLINICAL ENDOCRINOLOGY, 1987, 27 (01) : 115 - 120
  • [3] BLAHD WH, 1984, J NUCL MED, V25, P673
  • [4] LOW-LEVELS OF SERUM THYROGLOBULIN AFTER WITHDRAWAL OF THYROID SUPPRESSION THERAPY IN THE FOLLOW UP OF DIFFERENTIATED THYROID-CARCINOMA
    BRENDEL, AJ
    LAMBERT, B
    GUYOT, M
    JEANDOT, R
    DUBOURG, H
    ROGER, P
    WYNCHAUK, S
    MANCIET, G
    LEFORT, G
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (01): : 35 - 38
  • [5] SERUM THYROGLOBULIN LEVELS PREDICT TOTAL-BODY IODINE SCAN FINDINGS IN PATIENTS WITH TREATED WELL-DIFFERENTIATED THYROID-CARCINOMA
    CHARLES, MA
    DODSON, LE
    WALDECK, N
    HOFELDT, F
    GHAED, N
    TELEPAK, R
    OWNBEY, J
    BURSTEIN, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (03) : 401 - 407
  • [6] ECHENIQUE RL, 1982, J NUCL MED, V23, P235
  • [7] FUI SCN, 1979, BRIT MED J, V2, P298
  • [8] GIRELLI ME, 1985, EUR J NUCL MED, V10, P252
  • [9] CRITICAL-EVALUATION OF SERUM THYROGLOBULIN (TG) LEVELS DURING THYROID-HORMONE SUPPRESSION THERAPY VERSUS TG LEVELS AFTER HORMONE WITHDRAWAL AND TOTAL-BODY SCAN - RESULTS IN 291 PATIENTS WITH THYROID-CANCER
    GIRELLI, ME
    BUSNARDO, B
    AMERIO, R
    CASARA, D
    BETTERLE, C
    PICCOLO, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 11 (09): : 333 - 335
  • [10] HARLEY EH, 1988, ARCH OTOLARYNGOL, V114, P333